Erratum: The effect of PD-L1 testing on the cost-effectiveness and economic impact of immune checkpoint inhibitors for the second-line treatment of NSCLC [Ann Oncol, 28, 9, (2017) (2256-2263)] DOI: 10.1093/annonc/mdx305

P. N. Aguiar
, L. A. Perry
, J. Penny-Dimri
, H. Babiker
, H. Tadokoro
, R. A. de Mello
, G. L. Lopes

Surgery Monash Health

Research output: Contribution to journal › Comment / Debate › Other › peer-review

6 Citations (Scopus)

6 Citations
1 Article

1 results

Filter

2017

The effect of PD-L1 testing on the cost-effectiveness and economic impact of immune checkpoint inhibitors for the second-line treatment of NSCLC
Aguiar Jr., P. N., Perry, L. A., Penny-Dimri, J., Babiker, H., Tadokoro, H., de Mello, R. A. & Lopes Jr., G. L., Sept 2017, In: Annals of Oncology. 28, 9, p. 2256-2263 8 p.
Research output: Contribution to journal › Article › Research › peer-review

Open Access

74 Link opens in a new tab Citations (Scopus)